ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    presygen
Previous Study | Return to List | Next Study

Evaluate Ease of Use and Surgeons Opinions of Presygen™/Si-1 (Presygen™)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03715270
Recruitment Status : Not yet recruiting
First Posted : October 23, 2018
Last Update Posted : October 24, 2018
Sponsor:
Information provided by (Responsible Party):
Christie Medical Holdings, Inc.

Brief Summary:
This study is designed to evaluate the information provided to the clinicians by the surgical imaging device. It is also to gain insight on the user interface and how "user friendly" it is to the clinician.

Condition or disease Intervention/treatment
Perfusion; Complications Device: Image surgical area

Detailed Description:

Over the last decade, objective ways of measuring tissue oxygen have been introduced into the medical arena and are being used more and more for assessing ischemic events in tissue. Handheld Doppler ultrasound, infrared thermography, polarized spectral imaging, laser Doppler perfusion imaging, and fluorescence imaging have all been used with some degree of success. However, only a few have gained universal acceptance. [1] Multispectral imaging (MSI) which uses near-infrared (NIR) light to measure tissue oxygen levels in superficial tissue is another method that has been successfully used to assess tissue flap health.

The objective of this study is to conduct an evaluation of superficial tissue with Presygen™/si-1 in various patient types for surgical imaging during breast reconstruction. In addition, participating surgeons will complete a structured survey regarding their assessment of Presygen™/si-1 work station during the surgical procedure.

Primary Goal: Evaluation of superficial tissue in various patient types for surgical imaging during breast reconstruction.

Secondary Goal: Surgeon assessment of surgical work station during surgery through a prepared questionnaire.


Study Type : Observational
Estimated Enrollment : 25 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Non-randomized, Non-blinded, Convenience Sample to Evaluate the Surgical Imaging System
Estimated Study Start Date : November 2018
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : April 2019

Group/Cohort Intervention/treatment
breast reconstruction surgery patients
Patients will be imaged with imaging device (Presygen™/si-1) during surgical procedure. Image surgical area. Surgical procedure will follow standard of care. No clinical decisions will be made on device readings. A surgeon will complete a survey regarding his assessment of the imaging device.
Device: Image surgical area
Image surgical area
Other Name: Questionnaire on ease of use and general opinion




Primary Outcome Measures :
  1. Photographic, electronic and descriptive comparative analysis of superficial tissue oxygen saturation using Presygen™/si-1 for breast reconstruction subjects. [ Time Frame: 24 hours. ]
    Quantitative measures of tissue oxygen saturation for discrete locations on superficial tissue.


Secondary Outcome Measures :
  1. Quantitative survey providing surgeon assessment of work station during procedure. [ Time Frame: 24 hours ]
    completion of basic questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   22 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing breast reconstruction surgery and meet the inclusion and exclusion criteria.
Criteria

Inclusion Criteria:

  • Candidate for surgical intervention with breast reconstruction as part of the surgical plan
  • 22 years of age or older;
  • Able to understand and provide informed consent with HIPAA authorization.
  • Able to read and understand in English.

Exclusion Criteria:

  • Subjects who might need a legally-authorized representative
  • Subjects who possess diminished mental capabilities
  • Conditions that preclude imaging (excessive scarring, tattoos in surgical field, Fitzpatrick Scale VI)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03715270


Contacts
Contact: Eileen C Lane, MBA 760-419-8127 eileen.lane@christiedigital.com
Contact: Bruce D Cusson, RN 336-399-0414 bruce.cusson@christiedigital.com

Locations
United States, New Jersey
Englewood Hospital and Medical Cetner
Englewood, New Jersey, United States, 07631
Sponsors and Collaborators
Christie Medical Holdings, Inc.

Publications of Results:
Responsible Party: Christie Medical Holdings, Inc.
ClinicalTrials.gov Identifier: NCT03715270     History of Changes
Other Study ID Numbers: #E-18-741
First Posted: October 23, 2018    Key Record Dates
Last Update Posted: October 24, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Product Manufactured in and Exported from the U.S.: Yes